Chemoinformaics analysis of 3-METHYLCYCLOHEXAN-1-ONE
| Molecular Weight | 112.172 | nRot | 0 |
| Heavy Atom Molecular Weight | 100.076 | nRig | 7 |
| Exact Molecular Weight | 112.089 | nRing | 1 |
| Solubility: LogS | -0.999 | nHRing | 0 |
| Solubility: LogP | 1.194 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 20.4935 |
| nHD | 0 | BPOL | 12.9065 |
| QED | 0.466 |
| Synth | 2.686 |
| Natural Product Likeliness | 1.242 |
| NR-PPAR-gamma | 0.509 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.374 |
| MDCK | 0.0000287 |
| BBB | 0.998 |
| PPB | 0.28195 |
| VDSS | 0.878 |
| FU | 0.65903 |
| CYP1A2-inh | 0.324 |
| CYP1A2-sub | 0.828 |
| CYP2c19-inh | 0.105 |
| CYP2c19-sub | 0.561 |
| CYP2c9-inh | 0.039 |
| CYP2c9-sub | 0.778 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.745 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.181 |
| CL | 10.082 |
| T12 | 0.845 |
| hERG | 0.012 |
| Ames | 0.094 |
| ROA | 0.038 |
| SkinSen | 0.389 |
| Carcinogencity | 0.088 |
| EI | 0.985 |
| Respiratory | 0.198 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.952857 |